¾Ç¼º ¸²ÇÁÁ¾ Ä¡·á ÈÄ¿¡ ¹ß»ýÇÑ 9¹ø »ï¿°»öü¸¦ µ¿¹ÝÇÑ 2Â÷¼º ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´
Acute Myeloid Leukemia with Trisomy 9 Following Chemotherapy of Non-Hodgkin
¼Ò¼Ó »ó¼¼Á¤º¸
À强¿ø/Sung Won Jang
ÀÌ´ëÈÆ/ÃÖÁÖ¿¬/±èÈ«±â/ÃÖ¹ÎÈ£/±è¼±¿ì/¼Á¤°ï/ÁøÁ¾·ü/±èµ¿Áý/Dae Hoon Lee/Ju Yun Choil/Hong Gi Kim/Min Ho Choi/Sun Woo Kim/Jung Gon Suh/Jong Youl Jin/Dong Jip Kim
KMID : 0360319970290030512
Abstract
¼·Ð
Ç×¾Ï ¾à¹° Ä¡·áÀÇ ºÎÀÛ¿ë Áß ¹Ù¶÷Á÷ÇÏÁö ¸øÇÑ °Í ÁßÀÇ Çϳª´Â ÀÌÂ÷¼º ¾ÏÀ¸·Î, ±× Áß ±Þ¼º
°ñ¼ö¼º ¹éÇ÷º´ÀÌ °¡Àå ÈçÇѵ¥ ¼ºÀο¡°Ô ¾ËÅ³È ¾à¹°(alkylating agent) ¹×
epipodophyllotoxin(Non-inter-calating topoisomerase ¥± ¾ïÁ¦Á¦)À» »ç¿ëÇÔÀ¸·Î½á À¯¹ßµÇ´Â
°æ¿ì°¡ ¸¹´Ù. ¾ËÅ³È ¾à¹°¿¡ ÀÇÇÑ °æ¿ì´Â ÁÖ·Î Ç×¾Ï Ä¡·á ÈÄ 2Â÷¼º ¹éÇ÷º´ÀÌ »ý±æ ¶§±îÁöÀÇ
±â°£ÀÌ 2¡10³â(Æò±Õ 5³â)À¸·Î ±æ°í, ´ë°³ ¹üÇ÷±¸°¨¼ÒÁõÀ» µ¿¹ÝÇÑ °ñ¼ö ÀÌÇü¼ºÁõÀÌ ¼±ÇàÇÏ
¸ç, 5¹ø°ú 7¹ø ¿°»öü ÀÌ»óÀ» µ¿¹ÝÇÏ´Â °æ¿ì°¡ ¸¹´Ù. Epipodophyllotoxin¿¡ ÀÇÇÑ °æ¿ì´Â ¹é
Ç÷º´ ¹ßº´±îÁöÀÇ ±â°£ÀÌ Æò±Õ 15°³¿ù·Î ¾ËÅ³È ¾à¹°¿¡ ºñÇØ Âª°í, French -American
-British(FAB) ºÐ·ù»ó M4 ¶Ç´Â M5°¡ ¸¹À¸¸ç, ¹üÇ÷±¸°¨¼ÒÁõÀÌ ¾ø°í, ¿°»öü ÀÌ»óÀº llq23°ú
21q22¿¡ ÀüÀ§°¡ ÀÖ´Â °æ¿ì°¡ ¸¹´Ù. Anthracycline°ú °°Àº intercalating topoisomerase ¥± ¾ï
Á¦Á¦µµ ¾ÏÀ» ÀÏÀ¸Å°´Â °ÍÀ¸·Î º¸°íµÇ°í Àִµ¥ ¾ËÅ³È ¾à¹°°ú ÇÔ²² Åõ¿©ÇÑ °æ¿ì ±× ºóµµ°¡
³ô´Ù°í ¾Ë·ÁÁ® ÀÖ´Ù. ÀúÀÚµéÀº ¾ËųȾ๰ÀÎ cyclophosphamide¿Í anthracycline°è¿ÀÇ ¾à¹°
ÀÎ doxorubicinÀÌ Æ÷ÇÔµÈ º´ÇÕ ¾à¹° ¿ä¹ýÀ» ¾Ç¼º ¸²ÇÁÁ¾ ȯÀÚ¿¡°Ô Åõ¿©ÇÏ¿© °üÇظ¦ ¾ò¾úÀ¸
³ª 29°³¿ù ÈÄ 9¹ø »ï¿°»öü(trisomy 9) ÀÌ»óÀ» °¡Áø ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ÀÌ ¹ßº´ÇÏ¿© Áø´Ü 2
°³¿ù¸¸¿¡ »ç¸ÁÇÑ Áõ·Ê¸¦ °æÇèÇÏ¿´´Ù. ÀúÀÚµéÀÌ Á¶»çÇÑ ¹Ù·Î´Â Ç×¾Ï ¾à¹° Ä¡·á¿Í ¿¬°üµÈ 9¹ø
»ï¿°»öü ÀÌ»óÀÌ ÀÖ´Â 2Â÷¼º ¹éÇ÷º´Àº º¸°í°¡ ¾ø¾úÀ¸¹Ç·Î ÀÌ¿¡ º¸°íÇÏ´Â ¹ÙÀÌ´Ù.
#ÃÊ·Ï#
A 56-year-old male patient with non-Hodgkin's lymphoma achieved complete
remission in July 1994 after receiving MACOP-B chemotherapy. 29 months after
treatment, acute myeloid leukemia(AML, FAB subtypes M4) with trisomy 9 was
developed. To our knowledge this is the first report of therapy-related AML with
trisomy 9.
Å°¿öµå
AML; Trisomya; Secondary leukemia;
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸